Novo Nordisk A/S (NOVO:CA) Analyst/Investor Day September 21, 2026 4:00 AM EDT
Company Participants
Maziar Doustdar – President, CEO & Member of the Management Board
Martin Lange – EVP of R&D, Chief Scientific Officer and Member of the Management Board
Mishal Patel
Hong Chow – Executive VP of Product & Portfolio Strategy and Member of Management Board
Daniel Bohsen
Michael Novod – Senior VP & Head of Investor Relations
Habib Bennaceur
Jamey Millar – Executive VP of US Operations & Member of Management Board
Edward Cinca
Emil Larsen – EVP of International Operations & Member of Management Board
Kasper Mejlvang – Executive Vice President of CMC & Product Supply
Karsten Knudsen – Executive VP, CFO & Member of the Management Board
Thilde Bogebjerg – Executive VP of Enterprise IT & Quality and Member of Management Board
Tania Sabroe – EVP of People, Organisation and Corporate Affairs & Member of Management Board
Conference Call Participants
Richard Vosser – JPMorgan Chase & Co, Research Division
Seamus Fernandez – Guggenheim Securities, LLC, Research Division
Michael Leuchten – Jefferies LLC, Research Division
Sachin Jain – BofA Securities, Research Division
Simon Baker – Rothschild & Co Redburn, Research Division
Florent Cespedes – ODDO BHF Corporate & Markets, Research Division
Kerry Holford – Joh. Berenberg, Gossler & Co. KG, Research Division
Carsten Madsen – Danske Bank A/S, Research Division
Graham Glyn Parry – Citigroup Inc., Research Division
Thibault Boutherin – Morgan Stanley, Research Division
James Gordon – Barclays Bank PLC, Research Division
Rajesh Kumar
Peter Verdult – BNP Paribas, Research Division
Rune Dahl – DNB Carnegie, Research Division
Emmanuel Papadakis – Deutsche Bank AG, Research Division
Conversation
You must be logged in to post a comment Login